Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules.
Sestito S, Cirone I, Sagona S, Runfola M, Raffellini L, La Rocca V, Citi V, Martelli A, Daniele S, Lai M, Calderone V, Martini C, Manera C, Rapposelli S. Sestito S, et al. Among authors: daniele s. Eur J Med Chem. 2025 Feb 5;283:117175. doi: 10.1016/j.ejmech.2024.117175. Epub 2024 Dec 17. Eur J Med Chem. 2025. PMID: 39705734 Free article.
Discovery of the First-in-Class Dual TSPO/Carbonic Anhydrase Modulators with Promising Neurotrophic Activity.
Poggetti V, Angeloni E, Germelli L, Natale B, Waqas M, Sarno G, Angeli A, Daniele S, Salerno S, Barresi E, Cosconati S, Castellano S, Da Pozzo E, Costa B, Supuran CT, Da Settimo F, Taliani S. Poggetti V, et al. Among authors: daniele s. ACS Chem Neurosci. 2025 Jan 1;16(1):1-15. doi: 10.1021/acschemneuro.4c00477. Epub 2024 Nov 15. ACS Chem Neurosci. 2025. PMID: 39545683
Sex Differences in Blood Accumulation of Neurodegenerative-Related Proteins and Antioxidant Responses to Regular Physical Exercise.
Chelucci E, Scarfò G, Piccarducci R, Rizza A, Fusi J, Epifani F, Carpi S, Polini B, Betti L, Costa B, Taliani S, Cela V, Artini P, Daniele S, Martini C, Franzoni F. Chelucci E, et al. Among authors: daniele s. J Mol Neurosci. 2024 Nov 5;74(4):105. doi: 10.1007/s12031-024-02278-4. J Mol Neurosci. 2024. PMID: 39496982 Free PMC article.
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer.
Bardia A, Hu X, Dent R, Yonemori K, Barrios CH, O'Shaughnessy JA, Wildiers H, Pierga JY, Zhang Q, Saura C, Biganzoli L, Sohn J, Im SA, Lévy C, Jacot W, Begbie N, Ke J, Patel G, Curigliano G; DESTINY-Breast06 Trial Investigators. Bardia A, et al. N Engl J Med. 2024 Dec 5;391(22):2110-2122. doi: 10.1056/NEJMoa2407086. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282896 Clinical Trial.
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.
Bardia A, Jhaveri K, Im SA, Pernas S, De Laurentiis M, Wang S, Martínez Jañez N, Borges G, Cescon DW, Hattori M, Lu YS, Hamilton E, Zhang Q, Tsurutani J, Kalinsky K, Rubini Liedke PE, Xu L, Fairhurst RM, Khan S, Denduluri N, Rugo HS, Xu B, Pistilli B; TROPION-Breast01 Investigators. Bardia A, et al. J Clin Oncol. 2025 Jan 20;43(3):285-296. doi: 10.1200/JCO.24.00920. Epub 2024 Sep 12. J Clin Oncol. 2025. PMID: 39265124 Clinical Trial.
325 results